BioArctic AB has employed Nora Sjödin as responsible for Regulatory Affairs. She takes up her duties in the company today.
Nora Sjödin has long and extensive experience of global regulatory affairs operations from AstraZeneca, NDA Regulatory Service and most recently from Pharmalink.
”BioArctic is in a phase of strong development. We are very pleased to be able to employ Nora Sjödin, with her extensive regulatory affairs experience, from early development to products on the market. Nora will be an important asset to BioArctic’s strategic work with the development of our product portfolio,” says Gunilla Osswald, CEO of BioArctic.